What should you be doing with your MFs now? What should you be doing with your MFs now? Shashikant Singh / Tuesday, February 13, 2018 / Article rating: 4.0 You need to tactfully keep on booking profit and rebalance your portfolio to minimise LTCG burden.
Vakrangee hits upper circuit on capital allocation policy Vakrangee hits upper circuit on capital allocation policy Nikita Singh / Monday, February 12, 2018 / Article rating: 4.4 IT company Vakrangee hit its upper circuit on the bourses on Monday for the second consecutive trade session as the company announced its capital allocation policy, also announcing that it is a debt free company.
Bank Nifty surges nearly 1 per cent; still indecisive Bank Nifty surges nearly 1 per cent; still indecisive Amir Shaikh / Monday, February 12, 2018 / Article rating: 5.0 Bank Nifty index surged nearly 0.9 per cent, outpacing the benchmark indices, though marginally. The level of 25370 followed by 25150-25025 will act as major supports for the index.
Lupin launches generic version of Tamiflu in US Lupin launches generic version of Tamiflu in US Gayathri Udyawar / Monday, February 12, 2018 / Article rating: 5.0 Generics pharma giant Lupin announced the launch of Oseltamivir Phosphate Capsules in the US market. The drugmaker had earlier received USFDA approval for the same.
J Kumar Infraprojects reports healthy performance J Kumar Infraprojects reports healthy performance Amir Shaikh / Monday, February 12, 2018 / Article rating: 5.0 J Kumar Infraprojects' standalone revenue for the quarter came in at Rs. 457.16 crore, registering 23.9 per cent yoy increase.
Q3FY18 Results: Lumax Auto Tech reports PAT jump of 2.5 times Q3FY18 Results: Lumax Auto Tech reports PAT jump of 2.5 times Nidhi Jani / Monday, February 12, 2018 / Article rating: 5.0 The PAT for the quarter came in at Rs. 14.89 crore, yoy increase of 160.8 per cent. This was due to sharp jump in other income from Rs. 0.79 crore to Rs. 2.7 crore. Also, decline in interest expenses by 35 per cent yoy aided to bottomline growth.
Q3FY18 Results: Eris Lifesciences PAT jumps 10 per cent YoY Q3FY18 Results: Eris Lifesciences PAT jumps 10 per cent YoY Nidhi Jani / Monday, February 12, 2018 / Article rating: 5.0 The PAT for the quarter came in at Rs. 74.92 crore, yoy increase of 10 per cent. This was due to decline in effective tax rate from 5 to 3 per cent in Q3FY18.
Q3FY18 Results: PAT of Kwality melts by 53.6 per cent Q3FY18 Results: PAT of Kwality melts by 53.6 per cent Amir Shaikh / Monday, February 12, 2018 / Article rating: 5.0 The PAT for the quarter came in at Rs. 20.93 crore, yoy decline of 53.6 per cent. This was due to sharp decline in other income to Rs. 0.22 crore as against Rs. 5.03 crore in corresponding quarter of last year.
Behavioural biases that impact your Investment decisions Behavioural biases that impact your Investment decisions Nikhil Desai / Monday, February 12, 2018 / Article rating: 5.0 Irrespective of what asset classes you favour more, your behavioural tendencies will always play a great role in your success or failure as an investor. It's strange but true that the behavioural traps do impact your investment decision and wealth creations. Here are some behavioural traps/biases which should be avoided by mutual fund investors in the upcoming year.
Q3FY18 Results: Va Tech Wabag witnesses turnaround in bottomline Q3FY18 Results: Va Tech Wabag witnesses turnaround in bottomline Amir Shaikh / Monday, February 12, 2018 / Article rating: 5.0 During the quarter, the company witnessed turnaround in net profit to Rs. 35.83 crore as against Rs. 0.37 crore net loss in the corresponding quarter of last year.